Defitelio Injection, Solution
Product Images NDC 68727-800

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Defitelio (NDC 68727-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jazz Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Image 01 01)

Packaging label for Defitelio (defibrotide sodium) injection, 200 mg per 2.5 mL (80 mg/mL), for intravenous infusion. The label indicates it is a single-patient-use vial and must be diluted before infusion. Distributed by Jazz Pharmaceuticals, Inc. The package contains 10 sterile vials. Storage instructions and dosage administration notes are shown, along with barcodes and the NDC 68727-800-02.*

FDA Label Image

Chemical Structure (Image 02)

Chemical structure of defibrotide sodium showing repeating nucleotide units including adenine, guanine, cytosine, and thymine bases attached to a phosphate-deoxyribose backbone with sodium counterions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.